Please assess the completion status of the following clinical trial:

Trial Title: Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age of 18 at time of first visit.~2. HIV uninfected on the basis of a negative HIV Rapid Test~3. Possible non-occupational exposure to HIV-1, recent enough to permit receiving the first dose of study medication within 72 hours from the end of the exposure.~Exclusion Criteria:~1. Women who are actively trying to become pregnant.~2. Pregnancy and/or Breastfeeding.~3. Known self report of Chronic Hepatitis B infection or prior antiretroviral therapy for hepatitis B.~4. Known intolerance or allergy to study drugs.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Atazanavir, Ritonavir, Truvada (Type: OTHER): Open Label

Based on this trial design, predict the completion outcome and termination type (if applicable).